ROSPERO
Dead / Abandoned — Abandoned — no statement of use filed (as of 02 Oct 2023)
What this means for you
This application is over — abandoned 02 Oct 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90749011
- Mark type
- Stylized text
- Filed
- 02 Jun 2021
- Published for opposition
- 04 Jan 2022
- Abandoned
- 02 Oct 2023
- Attorney of record
- Cheryl L. Foytlin
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
Owner
- Janssen Sciences Ireland Unlimited Company, Ringaskiddy, Co. Cork, IE
- Janssen Sciences Ireland Unlimited Company, Ringaskiddy, Co. Cork, IE
Prosecution history
- 02 Oct 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 02 Oct 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 25 Feb 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Feb 2023 — SOU EXTENSION 2 GRANTED
- 23 Feb 2023 — SOU EXTENSION 2 FILED
- 23 Feb 2023 — SOU TEAS EXTENSION RECEIVED
- 16 Aug 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Aug 2022 — SOU EXTENSION 1 GRANTED
- 12 Aug 2022 — SOU EXTENSION 1 FILED
- 12 Aug 2022 — SOU TEAS EXTENSION RECEIVED
- 01 Mar 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Jan 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Jan 2022 — PUBLISHED FOR OPPOSITION
- 15 Dec 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Nov 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER